Duke, Merck KGaA and A2A cram in deals before ECB
Investors find room for varied names
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: